Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Dolca Insider Profile
4 Followers
Thomas Dolca, CMO at Principia Biopharma, holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY), holds 0.00 shares in Principia Biopharma (Ticker: PRNB), holds ― shares in Equillium (Ticker: EQ).
Thomas Dolca Principia Biopharma (PRNB)CMO
Principia Biopharma (PRNB)
CMO
Not Ranked
Thomas Dolca has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Thomas Dolca does not currently own shares as a corporate insider.
A breakdown of Thomas Dolca's holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Chinook Therapeutics
(KDNY)
(KDNY)
Rating:Informative Buy
Date:Sep 06, 2022 - Sep 06, 2023
Return:+98.40%
The most profitable trade made by Thomas Dolca
Thomas Dolca's Trading History
Principia Biopharma
Sep 28, 2020
―
Uninformative Sell
220.70K
$0.00
Chinook Therapeutics
Aug 11, 2023
―
Uninformative Sell
―
$0.00
Equillium
―
Chief Medical Officer
―
―
Allakos
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Thomas Dolca's performance on stock
You May Also Like
Thomas Dolca insider profile FAQ
What is the percentage of profitable transactions made by Thomas Dolca?
The percentage of profitable transactions made by Thomas Dolca is ―.
What is the average return per transaction made by Thomas Dolca?
The average return per transaction made by Thomas Dolca is ―.
What stocks does Thomas Dolca hold?
Thomas Dolca holds: PRNB, KDNY, EQ, ALLK stocks.
What was Thomas Dolca’s latest transaction?
Thomas Dolca latest transaction was an Uninformative Sell of ―.
What was Thomas Dolca's most profitable transaction?
Thomas Dolca’s most profitable transaction was an Informative Buy of KDNY stock on September 6, 2022. The return on the trade was 98.40%.
What is Thomas Dolca's role in Principia Biopharma?
Thomas Dolca's role in Principia Biopharma is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.